Clinical TrialsSearch results
Number of results: 322
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A multicenter phase II open-label study in untreated patients with CD20 positive indolent B-cell non-Hodgkin's lymphoma evaluating efficacy and safety of maintenance therapy with IDEC-C2B8.
- Untreated patients with CD20 positive indolent B-cell non-Hodgkin's lymphoma.
- Zenyaku Kogyo Co., Ltd.
- 2008-12-26
Other
- A multicenter randomized control study of the effect of umbilical cord milking in avoiding red cell transfusions in extremely immature infants
- extremely immature infants
- Neonatal Resarch Network
- 2008-01-23
Other
- A multicenter study on early prediction of antipsychotic response in patients with schizophrenia
- schizophrenia
- Juntendo University School of Medicine
- 2009-06-01
Other
- A multicenter study on warfarin use and optimal anticoagulation levels for prevention of cardiogenic embolism in Japanese patients with atrial fibrillation: J-RHYTHM Registry
- atrial fibrillation
- The Japanese Society of Electrocardiology
- 2009-01-05
Other
- A multicentre study on clinical usefulness of urinary trypsinogen-2 for early diagnosis of acute pancreatitis.
- Definite or possible acute pancreatitis.
- Division of Gastroenterology, Tohoku University Graduate School of Medicine
- 2009-01-07
Other
- A non-randomized confirmatory study of Limited Surgical Resection for Peripheral Early Lung Cancer Defined with Thoracic Thin-section Computed Tomography (JCOG0804/WJOG4507L)
- small (2 cm or less) peripheral radiological non-invasive lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-05-26
Other
- A open-label study of entecavir for chronic hepatitis B to determine the optimum duration of administration
- chronic hepatitis B
- Gunma Liver Study Group
- 2014-01-01
Other
- A open-label study of Entecavir in the patients with acute hepatitis B for preventing chronicity and aggravation
- Acute hepatitis B
- Gunma Liver Study Group
- 2013-10-01
Other
- A phase 2 multicenter study evaluating the safety and efficacy of Nilotinib in patients with Imatinib-resistant/intolerant Ph+CML in chronic phase
- Chronic myelogenous leukemia
- Shimousa Hematology Study Group
- 2009-06-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01